ネオヘスペリドシドのグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Neohesperidoside Market Insights and Forecast to 2028

• レポートコード：QY2203B04614
• 出版社/出版日：QYResearch / 2022年3月
• レポート形態：英文、PDF、112ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：化学＆材料

• 販売価格（消費税別）

Single User	￥686,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,029,000 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,372,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

新型コロナウイルス感染症のパンデミックにより、世界のネオヘスペリドシドの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にネオヘスペリドシドの世界市場のxxx％を占める「食品用」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「食品」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
中国のネオヘスペリドシドの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのネオヘスペリドシド市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのネオヘスペリドシド市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

ネオヘスペリドシドのグローバル主要メーカーには、Biospringer、BASF SE、Cargill、Chr.Hansen Holding A/S、Corbion NV、CP Kelco、DowDuPont、Edlong Dairy Technologies、Firmenich SA、FMC Health and Nutritionなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

ネオヘスペリドシド市場は、種類と用途によって区分されます。世界のネオヘスペリドシド市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
食品用、工業用、医薬品用

【用途別セグメント】
食品、化粧品、医薬品

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- ネオヘスペリドシド製品概要
- 種類別市場（食品用、工業用、医薬品用）
- 用途別市場（食品、化粧品、医薬品）
- 調査の目的
・エグゼクティブサマリー
- 世界のネオヘスペリドシド販売量予測2017-2028
- 世界のネオヘスペリドシド売上予測2017-2028
- ネオヘスペリドシドの地域別販売量
- ネオヘスペリドシドの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ネオヘスペリドシド販売量
- 主要メーカー別ネオヘスペリドシド売上
- 主要メーカー別ネオヘスペリドシド価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（食品用、工業用、医薬品用）
- ネオヘスペリドシドの種類別販売量
- ネオヘスペリドシドの種類別売上
- ネオヘスペリドシドの種類別価格
・用途別市場規模（食品、化粧品、医薬品）
- ネオヘスペリドシドの用途別販売量
- ネオヘスペリドシドの用途別売上
- ネオヘスペリドシドの用途別価格
・北米市場
- 北米のネオヘスペリドシド市場規模（種類別、用途別）
- 主要国別のネオヘスペリドシド市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのネオヘスペリドシド市場規模（種類別、用途別）
- 主要国別のネオヘスペリドシド市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のネオヘスペリドシド市場規模（種類別、用途別）
- 主要国別のネオヘスペリドシド市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のネオヘスペリドシド市場規模（種類別、用途別）
- 主要国別のネオヘスペリドシド市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのネオヘスペリドシド市場規模（種類別、用途別）
- 主要国別のネオヘスペリドシド市場規模（トルコ、サウジアラビア）
・企業情報
Biospringer、BASF SE、Cargill、Chr.Hansen Holding A/S、Corbion NV、CP Kelco、DowDuPont、Edlong Dairy Technologies、Firmenich SA、FMC Health and Nutrition
・産業チェーン及び販売チャネル分析
- ネオヘスペリドシドの産業チェーン分析
- ネオヘスペリドシドの原材料
- ネオヘスペリドシドの生産プロセス
- ネオヘスペリドシドの販売及びマーケティング
- ネオヘスペリドシドの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ネオヘスペリドシドの産業動向
- ネオヘスペリドシドのマーケットドライバー
- ネオヘスペリドシドの課題
- ネオヘスペリドシドの阻害要因
・主な調査結果

Market Analysis and Insights: Global Neohesperidoside Market
Due to the COVID-19 pandemic, the global Neohesperidoside market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Food Grade accounting for % of the Neohesperidoside global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Food segment is altered to an % CAGR throughout this forecast period.
China Neohesperidoside market size is valued at US$ million in 2021, while the US and Europe Neohesperidoside are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Neohesperidoside landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Neohesperidoside include Biospringer, BASF SE, Cargill, Chr.Hansen Holding A/S, Corbion NV, CP Kelco, DowDuPont, Edlong Dairy Technologies and Firmenich SA and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Neohesperidoside capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Neohesperidoside by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Neohesperidoside Scope and Segment
Neohesperidoside market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Neohesperidoside market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Food Grade
Industrial Grade
Pharmacy Grade
Segment by Application
Food
Cosmetics
Medicine
By Company
Biospringer
BASF SE
Cargill
Chr.Hansen Holding A/S
Corbion NV
CP Kelco
DowDuPont
Edlong Dairy Technologies
Firmenich SA
FMC Health and Nutrition
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

レポート目次

1 Study Coverage
1.1 Neohesperidoside Product Introduction
1.2 Market by Type
1.2.1 Global Neohesperidoside Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Food Grade
1.2.3 Industrial Grade
1.2.4 Pharmacy Grade
1.3 Market by Application
1.3.1 Global Neohesperidoside Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Food
1.3.3 Cosmetics
1.3.4 Medicine
1.4 Study Objectives
1.5 Years Considered
2 Global Neohesperidoside Production
2.1 Global Neohesperidoside Production Capacity (2017-2028)
2.2 Global Neohesperidoside Production by Region: 2017 VS 2021 VS 2028
2.3 Global Neohesperidoside Production by Region
2.3.1 Global Neohesperidoside Historic Production by Region (2017-2022)
2.3.2 Global Neohesperidoside Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Neohesperidoside Sales in Volume & Value Estimates and Forecasts
3.1 Global Neohesperidoside Sales Estimates and Forecasts 2017-2028
3.2 Global Neohesperidoside Revenue Estimates and Forecasts 2017-2028
3.3 Global Neohesperidoside Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Neohesperidoside Sales by Region
3.4.1 Global Neohesperidoside Sales by Region (2017-2022)
3.4.2 Global Sales Neohesperidoside by Region (2023-2028)
3.5 Global Neohesperidoside Revenue by Region
3.5.1 Global Neohesperidoside Revenue by Region (2017-2022)
3.5.2 Global Neohesperidoside Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Neohesperidoside Production Capacity by Manufacturers
4.2 Global Neohesperidoside Sales by Manufacturers
4.2.1 Global Neohesperidoside Sales by Manufacturers (2017-2022)
4.2.2 Global Neohesperidoside Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Neohesperidoside in 2021
4.3 Global Neohesperidoside Revenue by Manufacturers
4.3.1 Global Neohesperidoside Revenue by Manufacturers (2017-2022)
4.3.2 Global Neohesperidoside Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Neohesperidoside Revenue in 2021
4.4 Global Neohesperidoside Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Neohesperidoside Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Neohesperidoside Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Neohesperidoside Sales by Type
5.1.1 Global Neohesperidoside Historical Sales by Type (2017-2022)
5.1.2 Global Neohesperidoside Forecasted Sales by Type (2023-2028)
5.1.3 Global Neohesperidoside Sales Market Share by Type (2017-2028)
5.2 Global Neohesperidoside Revenue by Type
5.2.1 Global Neohesperidoside Historical Revenue by Type (2017-2022)
5.2.2 Global Neohesperidoside Forecasted Revenue by Type (2023-2028)
5.2.3 Global Neohesperidoside Revenue Market Share by Type (2017-2028)
5.3 Global Neohesperidoside Price by Type
5.3.1 Global Neohesperidoside Price by Type (2017-2022)
5.3.2 Global Neohesperidoside Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Neohesperidoside Sales by Application
6.1.1 Global Neohesperidoside Historical Sales by Application (2017-2022)
6.1.2 Global Neohesperidoside Forecasted Sales by Application (2023-2028)
6.1.3 Global Neohesperidoside Sales Market Share by Application (2017-2028)
6.2 Global Neohesperidoside Revenue by Application
6.2.1 Global Neohesperidoside Historical Revenue by Application (2017-2022)
6.2.2 Global Neohesperidoside Forecasted Revenue by Application (2023-2028)
6.2.3 Global Neohesperidoside Revenue Market Share by Application (2017-2028)
6.3 Global Neohesperidoside Price by Application
6.3.1 Global Neohesperidoside Price by Application (2017-2022)
6.3.2 Global Neohesperidoside Price Forecast by Application (2023-2028)
7 North America
7.1 North America Neohesperidoside Market Size by Type
7.1.1 North America Neohesperidoside Sales by Type (2017-2028)
7.1.2 North America Neohesperidoside Revenue by Type (2017-2028)
7.2 North America Neohesperidoside Market Size by Application
7.2.1 North America Neohesperidoside Sales by Application (2017-2028)
7.2.2 North America Neohesperidoside Revenue by Application (2017-2028)
7.3 North America Neohesperidoside Sales by Country
7.3.1 North America Neohesperidoside Sales by Country (2017-2028)
7.3.2 North America Neohesperidoside Revenue by Country (2017-2028)
7.3.3 U.S.
7.3.4 Canada
8 Europe
8.1 Europe Neohesperidoside Market Size by Type
8.1.1 Europe Neohesperidoside Sales by Type (2017-2028)
8.1.2 Europe Neohesperidoside Revenue by Type (2017-2028)
8.2 Europe Neohesperidoside Market Size by Application
8.2.1 Europe Neohesperidoside Sales by Application (2017-2028)
8.2.2 Europe Neohesperidoside Revenue by Application (2017-2028)
8.3 Europe Neohesperidoside Sales by Country
8.3.1 Europe Neohesperidoside Sales by Country (2017-2028)
8.3.2 Europe Neohesperidoside Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Neohesperidoside Market Size by Type
9.1.1 Asia Pacific Neohesperidoside Sales by Type (2017-2028)
9.1.2 Asia Pacific Neohesperidoside Revenue by Type (2017-2028)
9.2 Asia Pacific Neohesperidoside Market Size by Application
9.2.1 Asia Pacific Neohesperidoside Sales by Application (2017-2028)
9.2.2 Asia Pacific Neohesperidoside Revenue by Application (2017-2028)
9.3 Asia Pacific Neohesperidoside Sales by Region
9.3.1 Asia Pacific Neohesperidoside Sales by Region (2017-2028)
9.3.2 Asia Pacific Neohesperidoside Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
9.3.12 Philippines
10 Latin America
10.1 Latin America Neohesperidoside Market Size by Type
10.1.1 Latin America Neohesperidoside Sales by Type (2017-2028)
10.1.2 Latin America Neohesperidoside Revenue by Type (2017-2028)
10.2 Latin America Neohesperidoside Market Size by Application
10.2.1 Latin America Neohesperidoside Sales by Application (2017-2028)
10.2.2 Latin America Neohesperidoside Revenue by Application (2017-2028)
10.3 Latin America Neohesperidoside Sales by Country
10.3.1 Latin America Neohesperidoside Sales by Country (2017-2028)
10.3.2 Latin America Neohesperidoside Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Neohesperidoside Market Size by Type
11.1.1 Middle East and Africa Neohesperidoside Sales by Type (2017-2028)
11.1.2 Middle East and Africa Neohesperidoside Revenue by Type (2017-2028)
11.2 Middle East and Africa Neohesperidoside Market Size by Application
11.2.1 Middle East and Africa Neohesperidoside Sales by Application (2017-2028)
11.2.2 Middle East and Africa Neohesperidoside Revenue by Application (2017-2028)
11.3 Middle East and Africa Neohesperidoside Sales by Country
11.3.1 Middle East and Africa Neohesperidoside Sales by Country (2017-2028)
11.3.2 Middle East and Africa Neohesperidoside Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 U.A.E
12 Corporate Profiles
12.1 Biospringer
12.1.1 Biospringer Corporation Information
12.1.2 Biospringer Overview
12.1.3 Biospringer Neohesperidoside Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Biospringer Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Biospringer Recent Developments
12.2 BASF SE
12.2.1 BASF SE Corporation Information
12.2.2 BASF SE Overview
12.2.3 BASF SE Neohesperidoside Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 BASF SE Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 BASF SE Recent Developments
12.3 Cargill
12.3.1 Cargill Corporation Information
12.3.2 Cargill Overview
12.3.3 Cargill Neohesperidoside Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Cargill Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Cargill Recent Developments
12.4 Chr.Hansen Holding A/S
12.4.1 Chr.Hansen Holding A/S Corporation Information
12.4.2 Chr.Hansen Holding A/S Overview
12.4.3 Chr.Hansen Holding A/S Neohesperidoside Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Chr.Hansen Holding A/S Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Chr.Hansen Holding A/S Recent Developments
12.5 Corbion NV
12.5.1 Corbion NV Corporation Information
12.5.2 Corbion NV Overview
12.5.3 Corbion NV Neohesperidoside Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Corbion NV Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Corbion NV Recent Developments
12.6 CP Kelco
12.6.1 CP Kelco Corporation Information
12.6.2 CP Kelco Overview
12.6.3 CP Kelco Neohesperidoside Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 CP Kelco Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 CP Kelco Recent Developments
12.7 DowDuPont
12.7.1 DowDuPont Corporation Information
12.7.2 DowDuPont Overview
12.7.3 DowDuPont Neohesperidoside Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 DowDuPont Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 DowDuPont Recent Developments
12.8 Edlong Dairy Technologies
12.8.1 Edlong Dairy Technologies Corporation Information
12.8.2 Edlong Dairy Technologies Overview
12.8.3 Edlong Dairy Technologies Neohesperidoside Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Edlong Dairy Technologies Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Edlong Dairy Technologies Recent Developments
12.9 Firmenich SA
12.9.1 Firmenich SA Corporation Information
12.9.2 Firmenich SA Overview
12.9.3 Firmenich SA Neohesperidoside Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Firmenich SA Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Firmenich SA Recent Developments
12.10 FMC Health and Nutrition
12.10.1 FMC Health and Nutrition Corporation Information
12.10.2 FMC Health and Nutrition Overview
12.10.3 FMC Health and Nutrition Neohesperidoside Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 FMC Health and Nutrition Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 FMC Health and Nutrition Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Neohesperidoside Industry Chain Analysis
13.2 Neohesperidoside Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Neohesperidoside Production Mode & Process
13.4 Neohesperidoside Sales and Marketing
13.4.1 Neohesperidoside Sales Channels
13.4.2 Neohesperidoside Distributors
13.5 Neohesperidoside Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Neohesperidoside Industry Trends
14.2 Neohesperidoside Market Drivers
14.3 Neohesperidoside Market Challenges
14.4 Neohesperidoside Market Restraints
15 Key Finding in The Global Neohesperidoside Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Neohesperidoside Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Food Grade
Table 3. Major Manufacturers of Industrial Grade
Table 4. Major Manufacturers of Pharmacy Grade
Table 5. Global Neohesperidoside Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 6. Global Neohesperidoside Production by Region: 2017 VS 2021 VS 2028 (K MT)
Table 7. Global Neohesperidoside Production by Region (2017-2022) & (K MT)
Table 8. Global Neohesperidoside Production Market Share by Region (2017-2022)
Table 9. Global Neohesperidoside Production by Region (2023-2028) & (K MT)
Table 10. Global Neohesperidoside Production Market Share by Region (2023-2028)
Table 11. Global Neohesperidoside Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 12. Global Neohesperidoside Sales by Region (2017-2022) & (K MT)
Table 13. Global Neohesperidoside Sales Market Share by Region (2017-2022)
Table 14. Global Neohesperidoside Sales by Region (2023-2028) & (K MT)
Table 15. Global Neohesperidoside Sales Market Share by Region (2023-2028)
Table 16. Global Neohesperidoside Revenue by Region (2017-2022) & (US$ Million)
Table 17. Global Neohesperidoside Revenue Market Share by Region (2017-2022)
Table 18. Global Neohesperidoside Revenue by Region (2023-2028) & (US$ Million)
Table 19. Global Neohesperidoside Revenue Market Share by Region (2023-2028)
Table 20. Global Neohesperidoside Production Capacity by Manufacturers (2017-2022) & (K MT)
Table 21. Global Neohesperidoside Capacity Market Share by Manufacturers (2017-2022)
Table 22. Global Neohesperidoside Sales by Manufacturers (2017-2022) & (K MT)
Table 23. Global Neohesperidoside Sales Market Share by Manufacturers (2017-2022)
Table 24. Global Neohesperidoside Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 25. Global Neohesperidoside Revenue Share by Manufacturers (2017-2022)
Table 26. Neohesperidoside Price by Manufacturers 2017-2022 (USD/MT)
Table 27. Global Neohesperidoside Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Neohesperidoside by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neohesperidoside as of 2021)
Table 29. Neohesperidoside Manufacturing Base Distribution and Headquarters
Table 30. Manufacturers Neohesperidoside Product Offered
Table 31. Date of Manufacturers Enter into Neohesperidoside Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Neohesperidoside Sales by Type (2017-2022) & (K MT)
Table 34. Global Neohesperidoside Sales by Type (2023-2028) & (K MT)
Table 35. Global Neohesperidoside Sales Share by Type (2017-2022)
Table 36. Global Neohesperidoside Sales Share by Type (2023-2028)
Table 37. Global Neohesperidoside Revenue by Type (2017-2022) & (US$ Million)
Table 38. Global Neohesperidoside Revenue by Type (2023-2028) & (US$ Million)
Table 39. Global Neohesperidoside Revenue Share by Type (2017-2022)
Table 40. Global Neohesperidoside Revenue Share by Type (2023-2028)
Table 41. Neohesperidoside Price by Type (2017-2022) & (USD/MT)
Table 42. Global Neohesperidoside Price Forecast by Type (2023-2028) & (USD/MT)
Table 43. Global Neohesperidoside Sales by Application (2017-2022) & (K MT)
Table 44. Global Neohesperidoside Sales by Application (2023-2028) & (K MT)
Table 45. Global Neohesperidoside Sales Share by Application (2017-2022)
Table 46. Global Neohesperidoside Sales Share by Application (2023-2028)
Table 47. Global Neohesperidoside Revenue by Application (2017-2022) & (US$ Million)
Table 48. Global Neohesperidoside Revenue by Application (2023-2028) & (US$ Million)
Table 49. Global Neohesperidoside Revenue Share by Application (2017-2022)
Table 50. Global Neohesperidoside Revenue Share by Application (2023-2028)
Table 51. Neohesperidoside Price by Application (2017-2022) & (USD/MT)
Table 52. Global Neohesperidoside Price Forecast by Application (2023-2028) & (USD/MT)
Table 53. North America Neohesperidoside Sales by Type (2017-2022) & (K MT)
Table 54. North America Neohesperidoside Sales by Type (2023-2028) & (K MT)
Table 55. North America Neohesperidoside Revenue by Type (2017-2022) & (US$ Million)
Table 56. North America Neohesperidoside Revenue by Type (2023-2028) & (US$ Million)
Table 57. North America Neohesperidoside Sales by Application (2017-2022) & (K MT)
Table 58. North America Neohesperidoside Sales by Application (2023-2028) & (K MT)
Table 59. North America Neohesperidoside Revenue by Application (2017-2022) & (US$ Million)
Table 60. North America Neohesperidoside Revenue by Application (2023-2028) & (US$ Million)
Table 61. North America Neohesperidoside Sales by Country (2017-2022) & (K MT)
Table 62. North America Neohesperidoside Sales by Country (2023-2028) & (K MT)
Table 63. North America Neohesperidoside Revenue by Country (2017-2022) & (US$ Million)
Table 64. North America Neohesperidoside Revenue by Country (2023-2028) & (US$ Million)
Table 65. Europe Neohesperidoside Sales by Type (2017-2022) & (K MT)
Table 66. Europe Neohesperidoside Sales by Type (2023-2028) & (K MT)
Table 67. Europe Neohesperidoside Revenue by Type (2017-2022) & (US$ Million)
Table 68. Europe Neohesperidoside Revenue by Type (2023-2028) & (US$ Million)
Table 69. Europe Neohesperidoside Sales by Application (2017-2022) & (K MT)
Table 70. Europe Neohesperidoside Sales by Application (2023-2028) & (K MT)
Table 71. Europe Neohesperidoside Revenue by Application (2017-2022) & (US$ Million)
Table 72. Europe Neohesperidoside Revenue by Application (2023-2028) & (US$ Million)
Table 73. Europe Neohesperidoside Sales by Country (2017-2022) & (K MT)
Table 74. Europe Neohesperidoside Sales by Country (2023-2028) & (K MT)
Table 75. Europe Neohesperidoside Revenue by Country (2017-2022) & (US$ Million)
Table 76. Europe Neohesperidoside Revenue by Country (2023-2028) & (US$ Million)
Table 77. Asia Pacific Neohesperidoside Sales by Type (2017-2022) & (K MT)
Table 78. Asia Pacific Neohesperidoside Sales by Type (2023-2028) & (K MT)
Table 79. Asia Pacific Neohesperidoside Revenue by Type (2017-2022) & (US$ Million)
Table 80. Asia Pacific Neohesperidoside Revenue by Type (2023-2028) & (US$ Million)
Table 81. Asia Pacific Neohesperidoside Sales by Application (2017-2022) & (K MT)
Table 82. Asia Pacific Neohesperidoside Sales by Application (2023-2028) & (K MT)
Table 83. Asia Pacific Neohesperidoside Revenue by Application (2017-2022) & (US$ Million)
Table 84. Asia Pacific Neohesperidoside Revenue by Application (2023-2028) & (US$ Million)
Table 85. Asia Pacific Neohesperidoside Sales by Region (2017-2022) & (K MT)
Table 86. Asia Pacific Neohesperidoside Sales by Region (2023-2028) & (K MT)
Table 87. Asia Pacific Neohesperidoside Revenue by Region (2017-2022) & (US$ Million)
Table 88. Asia Pacific Neohesperidoside Revenue by Region (2023-2028) & (US$ Million)
Table 89. Latin America Neohesperidoside Sales by Type (2017-2022) & (K MT)
Table 90. Latin America Neohesperidoside Sales by Type (2023-2028) & (K MT)
Table 91. Latin America Neohesperidoside Revenue by Type (2017-2022) & (US$ Million)
Table 92. Latin America Neohesperidoside Revenue by Type (2023-2028) & (US$ Million)
Table 93. Latin America Neohesperidoside Sales by Application (2017-2022) & (K MT)
Table 94. Latin America Neohesperidoside Sales by Application (2023-2028) & (K MT)
Table 95. Latin America Neohesperidoside Revenue by Application (2017-2022) & (US$ Million)
Table 96. Latin America Neohesperidoside Revenue by Application (2023-2028) & (US$ Million)
Table 97. Latin America Neohesperidoside Sales by Country (2017-2022) & (K MT)
Table 98. Latin America Neohesperidoside Sales by Country (2023-2028) & (K MT)
Table 99. Latin America Neohesperidoside Revenue by Country (2017-2022) & (US$ Million)
Table 100. Latin America Neohesperidoside Revenue by Country (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Neohesperidoside Sales by Type (2017-2022) & (K MT)
Table 102. Middle East and Africa Neohesperidoside Sales by Type (2023-2028) & (K MT)
Table 103. Middle East and Africa Neohesperidoside Revenue by Type (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Neohesperidoside Revenue by Type (2023-2028) & (US$ Million)
Table 105. Middle East and Africa Neohesperidoside Sales by Application (2017-2022) & (K MT)
Table 106. Middle East and Africa Neohesperidoside Sales by Application (2023-2028) & (K MT)
Table 107. Middle East and Africa Neohesperidoside Revenue by Application (2017-2022) & (US$ Million)
Table 108. Middle East and Africa Neohesperidoside Revenue by Application (2023-2028) & (US$ Million)
Table 109. Middle East and Africa Neohesperidoside Sales by Country (2017-2022) & (K MT)
Table 110. Middle East and Africa Neohesperidoside Sales by Country (2023-2028) & (K MT)
Table 111. Middle East and Africa Neohesperidoside Revenue by Country (2017-2022) & (US$ Million)
Table 112. Middle East and Africa Neohesperidoside Revenue by Country (2023-2028) & (US$ Million)
Table 113. Biospringer Corporation Information
Table 114. Biospringer Description and Major Businesses
Table 115. Biospringer Neohesperidoside Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 116. Biospringer Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Biospringer Recent Development
Table 118. BASF SE Corporation Information
Table 119. BASF SE Description and Major Businesses
Table 120. BASF SE Neohesperidoside Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 121. BASF SE Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. BASF SE Recent Development
Table 123. Cargill Corporation Information
Table 124. Cargill Description and Major Businesses
Table 125. Cargill Neohesperidoside Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 126. Cargill Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Cargill Recent Development
Table 128. Chr.Hansen Holding A/S Corporation Information
Table 129. Chr.Hansen Holding A/S Description and Major Businesses
Table 130. Chr.Hansen Holding A/S Neohesperidoside Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 131. Chr.Hansen Holding A/S Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Chr.Hansen Holding A/S Recent Development
Table 133. Corbion NV Corporation Information
Table 134. Corbion NV Description and Major Businesses
Table 135. Corbion NV Neohesperidoside Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 136. Corbion NV Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Corbion NV Recent Development
Table 138. CP Kelco Corporation Information
Table 139. CP Kelco Description and Major Businesses
Table 140. CP Kelco Neohesperidoside Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 141. CP Kelco Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. CP Kelco Recent Development
Table 143. DowDuPont Corporation Information
Table 144. DowDuPont Description and Major Businesses
Table 145. DowDuPont Neohesperidoside Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 146. DowDuPont Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. DowDuPont Recent Development
Table 148. Edlong Dairy Technologies Corporation Information
Table 149. Edlong Dairy Technologies Description and Major Businesses
Table 150. Edlong Dairy Technologies Neohesperidoside Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 151. Edlong Dairy Technologies Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Edlong Dairy Technologies Recent Development
Table 153. Firmenich SA Corporation Information
Table 154. Firmenich SA Description and Major Businesses
Table 155. Firmenich SA Neohesperidoside Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 156. Firmenich SA Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Firmenich SA Recent Development
Table 158. FMC Health and Nutrition Corporation Information
Table 159. FMC Health and Nutrition Description and Major Businesses
Table 160. FMC Health and Nutrition Neohesperidoside Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022)
Table 161. FMC Health and Nutrition Neohesperidoside Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. FMC Health and Nutrition Recent Development
Table 163. Key Raw Materials Lists
Table 164. Raw Materials Key Suppliers Lists
Table 165. Neohesperidoside Distributors List
Table 166. Neohesperidoside Customers List
Table 167. Neohesperidoside Market Trends
Table 168. Neohesperidoside Market Drivers
Table 169. Neohesperidoside Market Challenges
Table 170. Neohesperidoside Market Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Neohesperidoside Product Picture
Figure 2. Global Neohesperidoside Market Share by Type in 2021 & 2028
Figure 3. Food Grade Product Picture
Figure 4. Industrial Grade Product Picture
Figure 5. Pharmacy Grade Product Picture
Figure 6. Global Neohesperidoside Market Share by Application in 2021 & 2028
Figure 7. Food
Figure 8. Cosmetics
Figure 9. Medicine
Figure 10. Neohesperidoside Report Years Considered
Figure 11. Global Neohesperidoside Capacity, Production and Utilization (2017-2028) & (K MT)
Figure 12. Global Neohesperidoside Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Neohesperidoside Production Market Share by Region (2017-2022)
Figure 14. Global Neohesperidoside Production Market Share by Region (2023-2028)
Figure 15. Neohesperidoside Production Growth Rate in North America (2017-2028) & (K MT)
Figure 16. Neohesperidoside Production Growth Rate in Europe (2017-2028) & (K MT)
Figure 17. Neohesperidoside Production Growth Rate in China (2017-2028) & (K MT)
Figure 18. Neohesperidoside Production Growth Rate in Japan (2017-2028) & (K MT)
Figure 19. Global Neohesperidoside Sales 2017-2028 (K MT)
Figure 20. Global Neohesperidoside Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 21. Global Neohesperidoside Revenue 2017-2028 (US$ Million)
Figure 22. Global Neohesperidoside Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 23. Global Neohesperidoside Sales Market Share by Region (2017-2022)
Figure 24. Global Neohesperidoside Sales Market Share by Region (2023-2028)
Figure 25. North America Neohesperidoside Sales YoY (2017-2028) & (K MT)
Figure 26. North America Neohesperidoside Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Europe Neohesperidoside Sales YoY (2017-2028) & (K MT)
Figure 28. Europe Neohesperidoside Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Neohesperidoside Sales YoY (2017-2028) & (K MT)
Figure 30. Asia-Pacific Neohesperidoside Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Latin America Neohesperidoside Sales YoY (2017-2028) & (K MT)
Figure 32. Latin America Neohesperidoside Revenue YoY (2017-2028) & (US$ Million)
Figure 33. Middle East & Africa Neohesperidoside Sales YoY (2017-2028) & (K MT)
Figure 34. Middle East & Africa Neohesperidoside Revenue YoY (2017-2028) & (US$ Million)
Figure 35. The Neohesperidoside Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 36. The Top 5 and 10 Largest Manufacturers of Neohesperidoside in the World: Market Share by Neohesperidoside Revenue in 2021
Figure 37. Neohesperidoside Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 38. Global Neohesperidoside Sales Market Share by Type (2017-2028)
Figure 39. Global Neohesperidoside Revenue Market Share by Type (2017-2028)
Figure 40. Global Neohesperidoside Sales Market Share by Application (2017-2028)
Figure 41. Global Neohesperidoside Revenue Market Share by Application (2017-2028)
Figure 42. North America Neohesperidoside Sales Market Share by Type (2017-2028)
Figure 43. North America Neohesperidoside Revenue Market Share by Type (2017-2028)
Figure 44. North America Neohesperidoside Sales Market Share by Application (2017-2028)
Figure 45. North America Neohesperidoside Revenue Market Share by Application (2017-2028)
Figure 46. North America Neohesperidoside Sales Share by Country (2017-2028)
Figure 47. North America Neohesperidoside Revenue Share by Country (2017-2028)
Figure 48. U.S. Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 49. Canada Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 50. Europe Neohesperidoside Sales Market Share by Type (2017-2028)
Figure 51. Europe Neohesperidoside Revenue Market Share by Type (2017-2028)
Figure 52. Europe Neohesperidoside Sales Market Share by Application (2017-2028)
Figure 53. Europe Neohesperidoside Revenue Market Share by Application (2017-2028)
Figure 54. Europe Neohesperidoside Sales Share by Country (2017-2028)
Figure 55. Europe Neohesperidoside Revenue Share by Country (2017-2028)
Figure 56. Germany Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 57. France Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 58. U.K. Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 59. Italy Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 60. Russia Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 61. Asia Pacific Neohesperidoside Sales Market Share by Type (2017-2028)
Figure 62. Asia Pacific Neohesperidoside Revenue Market Share by Type (2017-2028)
Figure 63. Asia Pacific Neohesperidoside Sales Market Share by Application (2017-2028)
Figure 64. Asia Pacific Neohesperidoside Revenue Market Share by Application (2017-2028)
Figure 65. Asia Pacific Neohesperidoside Sales Share by Region (2017-2028)
Figure 66. Asia Pacific Neohesperidoside Revenue Share by Region (2017-2028)
Figure 67. China Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 68. Japan Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 69. South Korea Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 70. India Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 71. Australia Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 72. Taiwan Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 73. Indonesia Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 74. Thailand Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 75. Malaysia Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 76. Philippines Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 77. Latin America Neohesperidoside Sales Market Share by Type (2017-2028)
Figure 78. Latin America Neohesperidoside Revenue Market Share by Type (2017-2028)
Figure 79. Latin America Neohesperidoside Sales Market Share by Application (2017-2028)
Figure 80. Latin America Neohesperidoside Revenue Market Share by Application (2017-2028)
Figure 81. Latin America Neohesperidoside Sales Share by Country (2017-2028)
Figure 82. Latin America Neohesperidoside Revenue Share by Country (2017-2028)
Figure 83. Mexico Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 84. Brazil Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 85. Argentina Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 86. Middle East and Africa Neohesperidoside Sales Market Share by Type (2017-2028)
Figure 87. Middle East and Africa Neohesperidoside Revenue Market Share by Type (2017-2028)
Figure 88. Middle East and Africa Neohesperidoside Sales Market Share by Application (2017-2028)
Figure 89. Middle East and Africa Neohesperidoside Revenue Market Share by Application (2017-2028)
Figure 90. Middle East and Africa Neohesperidoside Sales Share by Country (2017-2028)
Figure 91. Middle East and Africa Neohesperidoside Revenue Share by Country (2017-2028)
Figure 92. Turkey Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 93. Saudi Arabia Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 94. U.A.E Neohesperidoside Revenue (2017-2028) & (US$ Million)
Figure 95. Neohesperidoside Value Chain
Figure 96. Neohesperidoside Production Process
Figure 97. Channels of Distribution
Figure 98. Distributors Profiles
Figure 99. Bottom-up and Top-down Approaches for This Report
Figure 100. Data Triangulation
Figure 101. Key Executives Interviewed

以下、関連資料のご紹介

パルスチェイス解析のグローバル市場インサイト・予測（～2028年）

Global Pulse-chase Analysis Market Insights, Forecast to 2028
QY2203B04973 2022年3月 79Pages
新型コロナウイルス感染症のパンデミックにより、世界のパルスチェイス解析の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にパルスチェイス解析...

過活動膀胱（OAB）治療のグローバル市場インサイト・予測（～2028年）

Global Overactive Bladder Treatment Market Insights and Forecast to 2028
QY2203B08096 2022年3月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界の過活動膀胱（OAB）治療の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に過活動膀胱（...

スピンオンドーパントのグローバル市場インサイト・予測（～2028年）

Global Spin-on Dopant Market Insights, Forecast to 2028
QY2203B03540 2022年3月 77Pages
新型コロナウイルス感染症のパンデミックにより、世界のスピンオンドーパントの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にスピンオンドーパ...

GaNウェーハ用CMPパッド（GaN基板）のグローバル市場インサイト・予測（～2028年）

Global CMP Pads for GaN Wafer (GaN Substrate) Market Insights, Forecast to 2028
QY2203B00612 2022年3月 73Pages
新型コロナウイルス感染症のパンデミックにより、世界のGaNウェーハ用CMPパッド（GaN基板）の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、202...

ジブチルアミン(DBA)のグローバル市場インサイト・予測（～2028年）

Global Dibutylamine(DBA)(CAS 111-92-2) Market Insights and Forecast to 2028
QY2203B03170 2022年3月 92Pages
新型コロナウイルス感染症のパンデミックにより、世界のジブチルアミン(DBA)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にジブチルアミ...

N-エチルメタベースエステルのグローバル市場インサイト・予測（～2028年）

Global N-Ethyl Meta Base Ester Market Insights and Forecast to 2028
QY2203B00893 2022年3月 71Pages
新型コロナウイルス感染症のパンデミックにより、世界のN-エチルメタベースエステルの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にN-エチ...

医療用PFAのグローバル市場インサイト・予測（～2028年）

Global Medical Grade PFA Market Insights, Forecast to 2028
QY2203B07478 2022年3月 94Pages
新型コロナウイルス感染症のパンデミックにより、世界の医療用PFAの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に医療用PFAの世界市場の...

CO2回収プラントのグローバル市場インサイト・予測（～2028年）

Global CO2 Recovery Plant Market Insights, Forecast to 2028
QY2203B00478 2022年3月 111Pages
新型コロナウイルス感染症のパンデミックにより、世界のCO2回収プラントの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にCO2回収プラント...

スピーカーコネクタのグローバル市場インサイト・予測（～2028年）

Global Speaker Connectors Market Insights, Forecast to 2028
QY2203B03523 2022年3月 93Pages
新型コロナウイルス感染症のパンデミックにより、世界のスピーカーコネクタの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にスピーカーコネクタ...

PCAナトリウム（＆）アクアのグローバル市場インサイト・予測（～2028年）

Global Sodium PCA (and) Aqua Market Insights, Forecast to 2028
QY2203B00931 2022年3月 91Pages
新型コロナウイルス感染症のパンデミックにより、世界のPCAナトリウム（＆）アクアの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にPCAナ...

医療用PFAのグローバル市場インサイト・予測（～2028年） Perfluoroalkoxy (PFA) is a fully fluorinated translucent, slightly flexible polymer with a low coefficient of friction and outstanding antistick properties. This tough material resists stress cracking and attack by nearly all chemicals and solvents. PFA is also temperature resistant, making it ideal…
電子用プロピレン(C3H6)のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Electronic Grade Propylene (C3H6) Market Due to the COVID-19 pandemic, the global Electronic Grade Propylene (C3H6) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the re…
歯磨き粉用カルボキシメチルセルロースナトリウム（CMC）のグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Toothpaste Grade Sodium Carboxymethyl Cellulose (CMC) Market Due to the COVID-19 pandemic, the global Toothpaste Grade Sodium Carboxymethyl Cellulose (CMC) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ millio…
亜麻リグナンのグローバル市場インサイト・予測（～2028年） Flax Lignans, also known as open loop isoglucoside, is a plant estrogen very similar to human estrogen. It is known as an anticancer substance and is found in all kinds of fruits, vegetables, beans and cereals, but not in high amounts.Linseed is mainly found in linseed, and its content depends on th…
リキリチンのグローバル市場インサイト・予測（～2028年） Market Analysis and Insights: Global Liquiritin (CAS 551-15-5) Market Due to the COVID-19 pandemic, the global Liquiritin (CAS 551-15-5) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Ful…